Deepak Nitrite Q2 FY27 Profit Rises 235% to ₹398 Crore
Key highlights
- Deepak Nitrite reported Q2 FY27 profit after tax of ₹398 crore, up 235% year-on-year from ₹119 crore.
- Q2 FY27 total income rose 61% year-on-year to a record ₹3,091 crore.
- Deepak Nitrite reported EBITDA of ₹643 crore and an EBITDA margin of 21%, versus 12% in Q2 FY26.
- H1 FY27 total income reached ₹5,682 crore, up 48% from ₹3,836 crore in H1 FY26.
powered by IRIS

Deepak Nitrite Limited reported Q2 FY27 profit after tax of ₹398 crore, up 235% year-on-year from ₹119 crore, supported by a 61% increase in total income to ₹3,091 crore and a 21% EBITDA margin. The September-quarter performance marked record quarterly revenue and EBITDA for the company.
Know Deepak Nitrite inside out
Results, valuation, peers and who's buying, in one view.
What did Deepak Nitrite report for Q2 FY27?
Deepak Nitrite reported a sharp improvement in earnings for the quarter ended September 30, 2026. Total income increased to ₹3,091 crore from ₹1,922 crore in Q2 FY26, while revenue from operations rose to ₹3,076 crore from ₹1,902 crore. The company reported profit after tax of ₹398 crore, compared with ₹119 crore a year earlier.
The quarterly numbers also showed sequential growth. Revenue from operations was up 19% quarter-on-quarter, while profit after tax increased 15% from the preceding quarter. The company described the period as its best-ever quarterly operating performance in its more than five-decade history.
Management reported EBITDA of ₹643 crore for the quarter, a 187% year-on-year increase and a 16% sequential rise. EBITDA margin stood at 21%, compared with 12% in the corresponding quarter of the previous year. Profit before tax rose to ₹543 crore, while earnings per share increased to ₹29.16 from ₹8.71.
Which factors supported Deepak Nitrite's earnings growth?
Deepak Nitrite attributed the record performance to strong results in its Phenolics business. Management said Phenolics EBIT exceeded its previous full-year record within the first six months of FY27, indicating the scale of the division's contribution during the half year.
The improvement came despite what management described as a challenging operating environment. The supplied earnings material does not provide a numerical segment-wise revenue or profit split, so the precise contribution of individual product lines beyond the Phenolics commentary is not available from the reported information.
Higher profitability grew faster than revenue during the quarter. While total income rose 61% year-on-year, EBITDA increased 187% and net profit increased 235%. This was reflected in the expansion of EBITDA margin to 21% from 12% and the increase in profit after tax margin to 13% from 6%, based on the reported quarterly presentation figures.
How did the Q2 result compare with the first half?
Deepak Nitrite's total income for the April-September FY27 period reached ₹5,682 crore, up 48% from ₹3,836 crore in H1 FY26. Management said both revenue and EBITDA reached record levels for the half year as well as the September quarter.
The H1 number puts the Q2 outcome in a broader context. The company recorded strong growth through the first six months, with the second quarter contributing ₹3,091 crore of total income. The reported half-year data confirms continued momentum from the first quarter, although the supplied material does not provide a complete H1 profit or margin comparison.
For investors, the distinction between total income and revenue from operations is relevant. Deepak Nitrite reported total income of ₹3,091 crore for the quarter, while revenue from operations was ₹3,076 crore. Both figures were cited in the company-related disclosures, and each showed growth of roughly 61% year-on-year.
Got a follow-up? Ask IRIS
What did management communicate after the results?
Deepak Nitrite held its Q2 and H1 FY27 earnings conference call on October 30, 2026, following the board-result announcement on October 29. The company subsequently uploaded an audio recording of the call to its website, allowing shareholders to review management's discussion of the quarter and half-year performance.
The call included Maulik Mehta, Deputy Managing Director; Sanjay Upadhyay, Director Finance and Group CFO; and Somasekhar Nanda, CFO of Deepak Nitrite Limited. Management highlighted record revenue and EBITDA, the strength in Phenolics, and the company's capital allocation and balance-sheet update.
Management also indicated that Advanced Intermediates was looking towards a recovery in FY28. This was presented as a business outlook point rather than a quantified earnings forecast. The supplied information does not disclose a specific revenue target, margin target, project timetable, or capital expenditure amount for that recovery.
Why does the result matter for investors and the chemicals sector?
The results show that Deepak Nitrite's operating profitability improved materially during Q2 FY27. Revenue growth was accompanied by a 9-percentage-point increase in EBITDA margin, which helped profit after tax grow faster than the top line. The movement in margins is a central indicator for investors evaluating the quality of the quarterly earnings improvement.
For the wider chemical industry, the quarter illustrates how product mix and performance in key business divisions can influence financial results even in a difficult operating environment. Deepak Nitrite's stated Phenolics performance was the principal operational factor disclosed in the earnings commentary.
The market response reported alongside the results included a share-price rise of more than 3%. However, the provided material does not state the exact closing price, valuation, trading volume, or the date-specific benchmark comparison. Investors therefore have confirmed operating and financial data from the results, but limited source-backed information on the full market-price context.
Conclusion
Deepak Nitrite delivered record Q2 FY27 revenue and EBITDA, with total income of ₹3,091 crore and profit after tax of ₹398 crore. The 61% year-on-year increase in income, 235% rise in profit, and EBITDA margin expansion to 21% show that earnings growth was supported by a substantial improvement in operating profitability, with Phenolics identified as a key contributor.
The next reported item for shareholders is management's discussion available through the uploaded earnings-call recording. Investors will also watch for further disclosure on the Advanced Intermediates recovery outlook for FY28, including any future updates on operational progress, capital allocation, and segment-level financial performance.


